J.P. Morgan Healthcare Conference begins on Monday

By Admin
Share
This week, thousands of the top health executives and investors around the globe will attend the four-day J.P. Morgan Healthcare Conference at the Westi...

This week, thousands of the top health executives and investors around the globe will attend the four-day J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco.

The 34th annual conference is expected to bring in over 9,000 people, with some of the biggest names in the pharmaceutical sector in attendance. In addition, the conference primarily based in Union Square will include major hospitals, insurers, biotech firms and health care services companies.

RELATED TOPIC: Billionaire firm NantHealth to become IPO with Allscripts investment

It is the largest and oldest health investment conference in the industry, which continues to be the life science industry’s most popular event of the year. It also includes a two-day StartUp Health Festival where entrepreneurs attempt to connect with investors, customers and potential business partners.

Among the top topics this year is digital health, which has attracted interest. Investors put over $4.3 billion into digital health last year alone, which is a significant increase from the $1.1 billion in funding in 2011.

RELATED TOPIC: Is mHealth worth your venture capital investment?

“You’ve got thousands of investors coming into San Francisco for this J.P. Morgan conference, the biggest concentration of money in health care,” said StartUp Health co-founder Unity Stoakes. “We’ve never even been invited to the J.P. Morgan conference, so we decided to create our own festival at the gates of the conference.”

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma